Presidential Changes and Impact on Drug Related Misinformation

Misinformation around vaccines and treatments isn’t new, but with figures like Robert F. Kennedy Jr. in the spotlight, how should regulatory agencies respond?There will be potential changes coming to the FDA and public health regulations with the new administration. Historical transitions, such as the one from the Obama administration to the Trump administration, will shape policy going forward, particularly in terms of regulatory priorities. The government will need to combat misinforma...